The Substantia Nigra Is Where Parkinson's Starts

Parkinson's disease primarily damages a small region deep in the brain called the substantia nigra. This area sits at the base of the brain, in a section called the midbrain, and contains nerve cells that produce dopamine — a chemical messenger that controls movement, motivation, and mood.

In Parkinson's, these dopamine-producing cells die or stop working. The death happens slowly over years, which is why symptoms often appear gradually. By the time movement problems become noticeable, roughly 50 to 60 percent of the dopamine cells in the substantia nigra have already been lost. The brain can compensate for some cell loss, which is why people may not notice anything until the damage reaches a certain threshold.

The substantia nigra is part of a larger network called the basal ganglia, which sits beneath the brain's outer layer and coordinates smooth, automatic movement. When dopamine levels drop, this network misfires, and the signals that tell your muscles to move become scrambled or delayed.

Key Takeaways

  • Parkinson's destroys dopamine-producing cells in the substantia nigra, a small region at the base of the brain that controls movement and motivation.
  • Symptoms appear only after significant cell loss — usually 50 to 60 percent — because the brain can mask early damage.
  • The basal ganglia, which includes the substantia nigra, normally sends smooth movement signals; dopamine loss breaks this communication.
  • Lewy bodies, clumps of a protein called alpha-synuclein, accumulate in affected nerve cells and are a hallmark of Parkinson's damage.

How Dopamine Loss Breaks the Movement System

Dopamine acts as a traffic controller for movement signals. When dopamine levels are normal, the basal ganglia send clear, coordinated instructions to muscles: move your arm, walk forward, turn your head. The movement happens smoothly and without conscious effort — you do not have to think about each step when you walk.

With Parkinson's, dopamine depletion leaves the basal ganglia unable to filter and organize these signals properly. Competing instructions pile up, and the brain struggles to initiate movement or stop it once started. This is why people with Parkinson's experience tremor (shaking at rest), rigidity (stiff muscles), and bradykinesia (slow movement). The muscles themselves are not weak; the signal telling them to move has become unreliable.

The loss of dopamine also affects non-movement functions. Dopamine influences mood, motivation, sleep, and the ability to process reward. This is why Parkinson's often brings depression, fatigue, and sleep disturbance alongside the physical symptoms.

Lewy Bodies: The Cellular Hallmark of Parkinson's

Under a microscope, brain tissue from someone with Parkinson's shows clumps of protein called Lewy bodies. These are made of a protein called alpha-synuclein that has folded incorrectly and accumulated inside nerve cells. Scientists believe these clumps interfere with how cells function and eventually kill them.

Lewy bodies do not appear only in the substantia nigra. They also form in other brain regions — the cortex (outer layer), the locus coeruleus (which regulates alertness), and the dorsal motor nucleus of the vagus nerve (which controls digestion and heart rate). The spread of Lewy bodies to these other areas explains why Parkinson's causes symptoms beyond movement: constipation, low blood pressure, sleep behavior disorder, and cognitive changes.

Researchers still do not fully understand why alpha-synuclein misfolds in some people and not others, or what triggers the process. Genetics, environmental exposure, and aging all appear to play a role, but no single cause has been identified.

Why Symptoms Appear Gradually

The brain has built-in redundancy. Each region contains many more nerve cells than it strictly needs to function. When some cells die, neighboring cells can sometimes compensate by working harder or by adjusting their connections. This buffer means that early cell loss in the substantia nigra may cause no noticeable change in movement or mood.

As more dopamine cells die — typically over five to ten years before diagnosis — the brain's ability to compensate weakens. Eventually, dopamine levels drop below the threshold needed to maintain smooth movement, and symptoms become visible. A person might notice a slight tremor in one hand, or find that one arm does not swing naturally when walking. These early signs often go unrecognized because they are subtle and progress slowly.

This gradual onset is one reason Parkinson's is often diagnosed years after the disease process has begun. By the time someone sees a doctor, the underlying damage is already substantial, even if symptoms seem mild.

Other Brain Regions Affected as Parkinson's Progresses

Early Parkinson's primarily affects the substantia nigra and the movement circuits of the basal ganglia. But as the disease advances, Lewy bodies spread to other brain areas, and new symptoms emerge.

The locus coeruleus, a region that produces norepinephrine (a chemical that regulates alertness and attention), often develops Lewy bodies. Damage here contributes to fatigue, poor concentration, and mood changes. The dorsal motor nucleus of the vagus nerve, which controls involuntary functions like digestion and heart rate, is frequently affected early and explains why constipation and blood pressure problems are common in Parkinson's.

In later stages, Lewy bodies can reach the cortex — the brain's outer layer responsible for thinking, memory, and judgment. This spread is associated with cognitive decline and, in some cases, Parkinson's dementia. The timing and extent of cortical involvement varies widely between individuals, which is why some people with Parkinson's maintain sharp thinking for decades while others experience cognitive changes sooner.

How Brain Imaging Shows Parkinson's Damage

Doctors cannot see Lewy bodies or measure dopamine loss with standard imaging like CT or MRI scans. However, specialized imaging techniques can show the damage indirectly. PET scans using a tracer called fluorodopa can visualize dopamine production and show reduced uptake in the substantia nigra. DaT scans (dopamine transporter scans) use a radioactive tracer to map dopamine-producing cells and show the characteristic pattern of loss in Parkinson's.

These scans are not routine — they are used mainly when diagnosis is uncertain or when a doctor needs to rule out conditions that mimic Parkinson's. Most diagnoses are made based on symptoms and how the person responds to dopamine-replacement medication, not on imaging. The only definitive way to confirm Parkinson's is through autopsy, when brain tissue can be examined for Lewy bodies.

What Dopamine Replacement Does and Does Not Do

Medications like levodopa (Sinemet) work by increasing dopamine levels in the brain, which helps restore smoother movement signals. These drugs can dramatically improve tremor, rigidity, and slowness, especially in early Parkinson's. However, they do not stop or slow the death of dopamine cells — they only compensate for the dopamine that is already lost.

Over time, as more cells die, the brain's ability to convert medication into usable dopamine declines. Doses must be increased, and the duration of benefit from each dose shortens. This is why medication becomes less effective over years, not because the drug stops working, but because there are fewer cells left to respond to it.

Researchers are exploring whether other medications or therapies might slow the loss of dopamine cells, but no treatment currently available halts or reverses the underlying neurodegeneration. Understanding which brain regions are affected helps doctors predict which symptoms may appear next and tailor treatment accordingly.

Frequently Asked Questions

Can Parkinson's damage spread to other parts of the brain?

Yes. Lewy bodies typically begin in the substantia nigra and lower brainstem, then spread upward to the midbrain and eventually to the cortex. The pattern and speed of spread varies between individuals, which is why some people develop cognitive symptoms earlier than others.

Does Parkinson's affect the left side of the brain differently than the right?

Parkinson's usually affects one side of the brain more than the other, which is why symptoms often start on one side of the body — one hand trembles, or one leg feels stiff. Over time, both sides are typically involved, though one may remain more affected. The asymmetry is one clue that helps doctors distinguish Parkinson's from other movement disorders.

Is the damage from Parkinson's reversible?

No. Once dopamine cells die, they do not regenerate. Medications can help the remaining cells work better and can increase dopamine signaling, but they cannot restore dead cells. This is why Parkinson's is a progressive disease, though the rate of progression varies widely.

Can brain imaging show whether someone will develop Parkinson's before symptoms appear?

Specialized imaging can show reduced dopamine production before movement symptoms are obvious, but it is not used for screening. Researchers are studying whether early imaging might identify people at risk, but no test currently predicts who will develop Parkinson's or how quickly it will progress.

Why does Parkinson's affect dopamine cells but not other nerve cells?

Scientists do not yet know why dopamine cells in the substantia nigra are particularly vulnerable. These cells may be more sensitive to oxidative stress, or they may accumulate alpha-synuclein more readily. Genetics, environmental toxins, and aging likely all contribute, but the exact mechanism remains under investigation.